Description

Carisoprodol USP

Carisoprodol USP is a high-purity centrally acting skeletal muscle relaxant used in pharmaceutical formulations for the short-term treatment of musculoskeletal conditions. Compliant with United States Pharmacopeia (USP) standards, it is commonly utilized in oral dosage forms for relief of acute muscle pain and discomfort.
Carisoprodol is chemically designated as N-Isopropyl-2-Methyl-2-Propyl-1,3-Propanediol Dicarbamate. It appears as a white to off-white crystalline powder that is slightly soluble in water and freely soluble in alcohol, supporting formulation into tablets and other oral dosage forms.
In pharmaceutical and research applications, Carisoprodol USP is used in:
• Oral tablet formulations for acute musculoskeletal pain
• Short-term muscle relaxant therapy products
• Combination formulations with analgesics
• Research involving central nervous system depressants
• Pharmacokinetic and metabolism studies
• Development of muscle relaxant therapies
Carisoprodol USP functions through central nervous system activity, leading to sedation and alteration of interneuronal communication within the spinal cord and brain. This results in relief of muscle spasms and associated discomfort.
CarboMer supplies Carisoprodol USP with defined assay, impurity profile, and physicochemical characteristics suitable for regulated pharmaceutical manufacturing and formulation development.
The material meets USP monograph specifications and is appropriate for controlled pharmaceutical production environments.
The material is packaged in sealed, moisture-resistant, tamper-evident containers to preserve stability and handling quality. Available in laboratory, pilot, and commercial-scale quantities. Documentation includes Certificate of Analysis (CoA), Safety Data Sheet (SDS), and full traceability.
Each batch is tested for identity, assay, impurity profile, water content, and related substances where applicable. Technical support is available to assist with formulation development, stability considerations, and regulatory alignment.
As with all CarboMer supplied active pharmaceutical ingredients, Carisoprodol USP is supported by dependable global supply, rigorous quality systems, and expert technical guidance to ensure consistent and reliable performance across pharmaceutical applications.